Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

The solution contains sodium hydrogen carbonate, magnesium chloride, potassium chloride, sodium chloride and calcium ions. When infused, these ions disperse into the extracellular fluid, correcting deficits, providing bicarbonate buffering for metabolic acidosis, and supporting osmotic equilibrium essential for renal replacement and fluid‑management therapies.

The dose of Multibic is determined by the prescribing clinician based on the patient’s electrolyte profile, fluid status, and the specific clinical situation. Dosage may be adjusted during haemodialysis sessions or other intravenous therapy, and should follow the healthcare professional’s instructions.

Safety data for Multibic in pregnancy and lactation are limited. Use is only recommended if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Multibic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Multibic offers a balanced combination of sodium, potassium, calcium, magnesium and bicarbonate, making it suitable for both electrolyte replacement and acid‑base correction. Compared with single‑ion solutions, it reduces the need for multiple infusions and helps streamline fluid management during dialysis or critical‑care settings.

Multibic should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations. Inspect the container for any signs of damage before use and discard if the solution appears discolored or particulate.

Multibic is administered intravenously, either as a continuous infusion during haemodialysis or as a bolus injection when rapid electrolyte correction is needed. Administration should be performed by trained healthcare personnel using aseptic technique and appropriate infusion equipment.

Serious risks include severe hyperkalemia or hypernatremia, fluid overload leading to pulmonary edema, metabolic alkalosis, and rare allergic reactions such as anaphylaxis. Continuous monitoring of electrolyte levels, cardiac rhythm and fluid balance is essential to detect and manage these complications promptly.

Multibic should be avoided in patients with known hypersensitivity to any of its components, uncontrolled severe hyperkalemia or hypernatremia, and in those where fluid overload is a contraindication. Clinicians should also exercise caution in patients with severe cardiac arrhythmias or uncompensated metabolic disorders.